LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 16.29 | 84.90 | 946 | 766 | 1.2336 | 1.1367 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 17.99 | 84.90 | 934 | 898 | 1.0390 | 1.0226 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 17.99 | 84.90 | 1087 | 898 | 1.2092 | 1.1147 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 17.99 | 84.90 | 6 | 898 | 0.0067 | -0.5408 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 17.99 | 84.90 | 821 | 898 | 0.9133 | 0.9474 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 19.69 | 84.90 | 940 | 1239 | 0.7584 | 0.8620 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 19.69 | 84.90 | 1030 | 1239 | 0.8310 | 0.9066 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 19.69 | 84.90 | 8 | 1239 | 0.0065 | -0.4570 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 19.69 | 84.90 | 958 | 1239 | 0.7729 | 0.8712 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 21.40 | 84.90 | 1011 | 1454 | 0.6950 | 0.8301 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 21.40 | 84.90 | 1061 | 1454 | 0.7294 | 0.8518 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 21.40 | 84.90 | 14 | 1454 | 0.0096 | -0.3558 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 21.40 | 84.90 | 956 | 1454 | 0.6572 | 0.8053 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 23.10 | 84.90 | 1120 | 1616 | 0.6930 | 0.8347 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 23.10 | 84.90 | 1163 | 1616 | 0.7196 | 0.8510 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 23.10 | 84.90 | 15 | 1616 | 0.0093 | -0.3349 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 23.10 | 84.90 | 983 | 1616 | 0.6082 | 0.7792 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 24.81 | 84.90 | 1026 | 1769 | 0.5798 | 0.7661 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 24.81 | 84.90 | 1059 | 1769 | 0.5985 | 0.7789 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 24.81 | 84.90 | 16 | 1769 | 0.0090 | -0.3167 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 24.81 | 84.90 | 1112 | 1769 | 0.6284 | 0.7988 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 26.51 | 84.90 | 1158 | 1923 | 0.6021 | 0.7869 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 26.51 | 84.90 | 1189 | 1923 | 0.6183 | 0.7974 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 26.51 | 84.90 | 15 | 1923 | 0.0078 | -0.3196 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 26.51 | 84.90 | 1076 | 1923 | 0.5595 | 0.7579 | MN20160318_Q02 | H18 |